UBE2C: A pan-cancer diagnostic and prognostic biomarker revealed through bioinformatics analysis.

In summary, UBE2C can be a theranostic gene, which may serve as a reliable biomarker in diagnosing cancers, improving treatment responses and increasing the overall survival of cancer patients and can be a promising gene to be target by cancer drugs in the future.